ReviewAmerican journal of hematology2022

Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.

Jonathan D Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.